Experience with infliximab (anti-TNF alpha monoclonal antibody) as monotherapy for giant cell arteritis

Ann Rheum Dis. 2003 Nov;62(11):1116. doi: 10.1136/ard.62.11.1116.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Aged, 80 and over
  • Antibodies, Monoclonal / therapeutic use*
  • Antirheumatic Agents / therapeutic use*
  • Giant Cell Arteritis / drug therapy*
  • Humans
  • Infliximab
  • Male
  • Time Factors

Substances

  • Antibodies, Monoclonal
  • Antirheumatic Agents
  • Infliximab